Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000389494

Medchemexpress LLC Sinapine (thiocyanate) | 7431-77-8 | 368.45 | 25 MG
SDP

Catalog No. 5000389494
Encompass_Preferred

Sinapine thiocyanate is an alkaloid isolated from the seeds of cruciferous species. It exhibits various beneficial effects, including anti-inflammatory, anti-oxidant, anti-tumor, anti-angiogenic, and radio-protective properties. It also acts as an acetylcholinesterase (AChE) inhibitor and is researched for its potential in treating neurological disorders such as Alzheimer's disease, ataxia, myasthenia gravis, and Parkinson's disease.

  • Can counteract H2O2 and antimycin A-induced mitochondrial oxidative stress in cardiomyocytes.
  • Inhibits the proliferation of Caco-2 cells in a dose-dependent manner and has relatively low toxicity.
  • Promotes doxorubicin accumulation in Caco-2 cells by decreasing P-glycoprotein (P-gp).
  • Reduces phosphorylation of FRS2α and ERK1/2.
  • Reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota.

Catalog No. 50-003-89494 Supplier Medchemexpress LLC Supplier No. 25MGHYN0450
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Sinapine thiocyanate is an alkaloid isolated from the seeds of cruciferous species. It exhibits various beneficial effects, including anti-inflammatory, anti-oxidant, anti-tumor, anti-angiogenic, and radio-protective properties. It also acts as an acetylcholinesterase (AChE) inhibitor and is researched for its potential in treating neurological disorders such as Alzheimer's disease, ataxia, myasthenia gravis, and Parkinson's disease.

  • Can counteract H2O2 and antimycin A-induced mitochondrial oxidative stress in cardiomyocytes.
  • Inhibits the proliferation of Caco-2 cells in a dose-dependent manner and has relatively low toxicity.
  • Promotes doxorubicin accumulation in Caco-2 cells by decreasing P-glycoprotein (P-gp).
  • Reduces phosphorylation of FRS2α and ERK1/2.
  • Reduces non-alcoholic fatty liver disease in mice by modulating the composition of the gut microbiota.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.